Amina Ismail
Impact in
- Health top 5%
- Vaccine Coverage and Hesitancy
- Microbiology top 5%
- Bacterial Infections and Vaccines
Papers in
-
- Virology and Viral Diseases 2
-
- Viral gastroenteritis research and epidemiology 2
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Karen Cowgill (2 shared papers)J. Anthony G. Scott (2 shared papers)Charles R. Newton (2 shared papers)Moses Ndiritu (2 shared papers)Tatu Kamau (2 shared papers)Daniel R. Feikin (2 shared papers)Mary Slack (1 shared paper)Joyce U. Nyiro (1 shared paper)
- Journals
- JAMA (1 paper)Vaccine (1 paper)BMC Public Health (1 paper)Journal of Pediatric and Adolescent Gynecology (1 paper)The Pediatric Infectious Disease Journal (1 paper)
- Partner nations
- United StatesKenyaRepublic of the Congo
In The Last Decade
Amina Ismail
7 papers receiving 282 citations
Peers
Comparison fields: 5 of 50
- Health 115
- Microbiology 72
- Epidemiology 160
- Hepatology 27
- Modeling and Simulation 15
Countries citing papers authored by Amina Ismail
This map shows the geographic impact of Amina Ismail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amina Ismail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amina Ismail more than expected).
Fields of papers citing papers by Amina Ismail
This network shows the impact of papers produced by Amina Ismail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amina Ismail. The network helps show where Amina Ismail may publish in the future.
Co-authors
The 25 scholars most cited alongside Amina Ismail, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 139 | |
| 2 | 2006 | 101 | |
| 3 | 2012 | 21 | |
| 4 | 2013 | 14 | |
| 5 | 2017 | 6 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 5 | |
| 8 | Implementing the PAWS Model of capacity building in South Africa | 2009 | 1 |
About Amina Ismail
Amina Ismail is a scholar working on Epidemiology, Infectious Diseases, Health, Cardiology and Cardiovascular Medicine and Hepatology, having authored 8 papers that have together received 292 indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (3 papers), Hepatitis Viruses Studies and Epidemiology (2 papers), Virology and Viral Diseases (2 papers), Viral gastroenteritis research and epidemiology (2 papers), Viral Infections and Immunology Research (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Public-Private Partnership Projects (1 paper) and Menstrual Health and Disorders (1 paper). The work is most often cited by research in Health (115 citations), Microbiology (72 citations), Epidemiology (160 citations), Hepatology (27 citations) and Modeling and Simulation (15 citations). Amina Ismail has collaborated with scholars based in United States, Kenya and Republic of the Congo. Frequent co-authors include Karen Cowgill, J. Anthony G. Scott, Charles R. Newton, Moses Ndiritu, Tatu Kamau, Daniel R. Feikin, Mary Slack, Joyce U. Nyiro, Mike English and Isaiah Mwangi. Their work appears in journals such as JAMA, Vaccine, BMC Public Health, Journal of Pediatric and Adolescent Gynecology and The Pediatric Infectious Disease Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.